Catalio Capital closes over $400M Fund IV

Venture Capital Farm Cattleo Capital Management Announced today Iv to turn off the funds of more than $ 400 million, Bloomberg reported as the first. Fund will continue the thesis of the firm that supports healthcare and biotechnology companies.

The firm was established in 2021 and has invested more than 100 according to the pitchbook. Specifically, Cattleio Fund IV, especially the diagnostics agency PinkDX and drug discoveries, have already supported 16 companies, including superluminous drugs.

The farm earned a $ 381 million fund in the first 2020 III and pitchbook to raise a 100 million $ II in II in 2019.

Particularly the biotech market was not immune to the last year’s initiative, then higher interest rates and a cooler IPO market. According to the Bloomberg report, last year, the market increased by only $ 12 billion last year, which has decreased from the peak of $ 152.3 billion in 2023.